Subsequently, a case-control study including 438 controls and 410 patients with sporadic gastric carcinoma provided evidence supporting the association of MDM2 SNP309 with both an increased susceptibility to gastric carcinoma and poor prognosis [26]. The gene discussed is MDM2; the disease is gastric carcinoma.